Blue Cross Blue Shield Iowa ABA Coverage & Prior Auth | OpenPayer
CurrentBlue Cross Blue Shield - IowaPolicy N/A
Applied Behavior Analysis (ABA) for the Treatment of Autism
Defines medical necessity, prior approval, documentation, and provider requirements for outpatient (and incorporated inpatient/residential/PHP) ABA therapy for treatment of autism spectrum disorder for Wellmark/Blue Cross Blue Shield - Iowa members.
Policy Summary
PayerBlue Cross Blue Shield - Iowa
PolicyApplied Behavior Analysis (ABA) for the Treatment of Autism
Policy CodePolicy N/A
Change TypeNo material changes
Effective DateDec 1, 2016
Next Review Date
Key ActionSubmit prior authorization requests with a complete BCBA-authored medical record including assessments, individualized measurable goals, and collected progress data.
No material clinical or coverage changes in this revision.
Prior approvalAuthorization requirement for outpatient ABA
6 monthsRoutine review interval
3 monthsEarliest concurrent review
RestrictedTelehealth
50%Improvement threshold
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.
Coverage Criteria for ABA Services
Initial ABA Treatment Assessment
Initial assessment may be considered medically necessary when ALL the following are met:
Diagnosis and medical evaluation: Individual has a diagnosis of ASD consistent with DSM-5 and a medical evaluation including neurological examination has been completed.
From initial assessment section
Provider qualifications: Any individual providing or supervising ABA must be either a licensed MD/DO or psychologist in the state where services are performed, OR a BACB-certified provider (undergraduate-level certificants must be supervised by BCBA/BCBA-D).
Credential and supervision requirement
Initial Treatment Criteria
Initial ABA treatment may be considered medically necessary when ALL the following are met:
Non-duplication: Recommended ABA services do not duplicate services provided or available to the member by other medical or behavioral health professionals (e.g., individual/group/family therapy, OT, PT, speech therapy).
Non-duplication requirement
Focus on core ASD deficits: Approved treatment goals and clinical documentation focus on active ASD core symptoms and deficits that inhibit daily functioning and include a plan for stimulus and response generalization in novel contexts.
Goal focus requirement
Treatment scope: Either: (a) Comprehensive treatment directed toward reducing the gap between chronological and developmental ages to develop or restore function; OR (b) Focused treatment designed to reduce the burden of selected targeted symptoms and increase appropriate alternative behaviors.
Choice of treatment scope
Least restrictive setting and appropriate intensity: Treatment is provided in the least restrictive and most clinically appropriate environment; intensity does not exceed the member's functional ability to participate and is not for convenience.
Setting and intensity
Individualization: Treatment is clinically appropriate and individualized for type, frequency, intensity, extent, site, and duration and occurs where target behaviors are occurring or where treatment is likely to impact behaviors.
Individualized plan requirement
Provider qualifications: Provider or supervisor must be a licensed MD/DO or psychologist in-state or BACB-certified (BCBA/BCBA-D); undergraduate-level certificants must be supervised by BCBA/BCBA-D.
Provider credential requirement
Initial Request Documentation
The initial request must include a comprehensive medical record submitted by the BCBA containing ALL of the following:
Preferred assessments: Developmentally and age-appropriate assessments such as ABLLS, VB-MAPP, or other developmental measurements employed.
Assessment list
Individualized treatment plan and goals: Individualized treatment plan with clinically significant, measurable goals addressing core ASD deficits; goals written with measurable criteria reasonably achievable within six months and including date introduced, estimated mastery date, and plan for generalization.
Goal documentation specifics
Functional Behavior Assessment (FBA): Functional Behavior Assessment addressing targeted problematic behaviors with operational definitions and data to measure progress, as clinically indicated.
FBA requirement
Continued Treatment Criteria
Continued treatment may be considered medically necessary when ALL the following are met:
Non-duplication: ABA services do not duplicate services provided or available from other medical or behavioral health professionals (e.g., individual/group/family therapy, OT, PT, speech therapy).
Continued non-duplication
Goal-focused documentation: Approved treatment goals and documentation remain focused on active ASD core symptoms and deficits with a plan for stimulus and response generalization.
Continued treatment is considered medically necessary when ALL of the following are met:
Demonstrated improvement: On concurrent review, current ABA treatment must demonstrate significant improvement and clinically significant progress; significant improvement is defined as mastery of a minimum of 50% of stated goals in the submitted treatment plan.>=50% goals mastered
If <50% mastered, treatment plan should address barriers to success.
Expectation of mastery: There are reasonable expectations that proposed goals can be mastered within the requested six-month treatment period and that achievement will assist in independence and functional improvements; continued six-month goals must connect to long-term clinically significant goals.6 months per goal set
Connection to long-term outcomes
Capacity to generalize skills: There is reasonable expectation that the individual can acquire and develop clinically significant generalized skills to assist independence and function.
Resumption of Treatment
Resumption of ABA after prior treatment ended may be considered medically necessary when ALL the following are met:
Time since prior treatment: A minimum of 12 months has elapsed since the end of previous ABA treatment.12 months
Initial criteria met: Medical necessity criteria for initial assessment and treatment are met (see initial assessment and initial treatment criteria).
Evidence summaries influencing coverage stance
Summary of key evidence and implications for coverage decisions:
Children - early intensive ABA evidence: An individual participant data meta-analysis (10 nonrandomized studies; 491 participants) and other trials report improvements in Vineland adaptive behavior and IQ at ~1–2 years for some children receiving early intensive ABA-based interventions versus TAU/eclectic, but included studies have methodological limitations, risk of bias, and limited long-term follow-up, reducing certainty of long-term benefit.
Effects vary across studies; further comparative long-term research needed.
Adults - evidence: Evidence for adults with ASD is limited to small case studies and few trials; no controlled trials reporting clinically important functional outcomes were identified, limiting ability to confirm benefit for adults.
Controlled studies with prespecified clinically meaningful outcomes are needed.
Coverage for Applied Behavior Analysis (ABA) is limited to the treatment of autism spectrum disorder (ASD). ABA services for indications other than ASD are not a covered benefit — coverage is determined by the member's benefit plan and services for non-ASD indications are excluded. Services provided in or as part of an educational setting, performed as part of a scholastic program, or provided as a replacement for services that are the responsibility of the educational system are considered non-covered benefits and will be denied.
Parent or caregiver support groups are explicitly considered not medically necessary. While individualized caregiver training as part of an ABA program is expected, attendance in general parent support groups does not meet medical necessity criteria and is excluded from coverage.
ABA is not medically necessary when used to achieve nonspecific behavioral change or general improvement without time-limited, measurable treatment goals. Interventions provided primarily as supportive care, to produce broad or non-targeted behavioral improvements, or when a less intensive service would likely achieve equivalent therapeutic results are not covered.
Regulatory note: Applied Behavior Analysis (ABA) is not regulated by the U.S. Food and Drug Administration (FDA).
Evidence in adults with ASD is limited. Available literature consists primarily of small case studies and few trials; systematic reviews found case reports showing behavioral changes but no controlled trials reporting clinically important functional outcomes. Because high-quality controlled evidence demonstrating improved functional status in adults is lacking, broad coverage of ABA for adults to improve health outcomes is not supported without additional comparative trials using established outcome measures.
Supplemental guideline and reference material included in this policy are provided for clinician reference only. Inclusion of these resources does not imply endorsement of their conclusions or alignment with the policy's evidence review and coverage determinations.
Services that duplicate educational programs or are provided as part of scholastic education are not covered. Similarly, interventions provided primarily for convenience — rather than to meet individualized, measurable medical goals — are not medically necessary. Parent support groups and other activities that effectively duplicate educational services or serve convenience needs are excluded from coverage.
Reasons continuation of ABA may be denied include documentation that treatment goals have been achieved or maximum benefit reached; caregivers refusing or being unable to participate to an extent that compromises effectiveness; treatment-related exacerbation of behaviors; determination that the individual is unlikely to continue to benefit; or lack of clinically significant improvement for at least 3 months in targeted domains (adaptive function, social/family interactions, communication/language, or behaviors interfering with functioning).
Reiterating evidence limitations in adults: the literature does not include controlled trials reporting clinically important functional outcomes for adults with ASD. Because comparative evidence is insufficient, ABA for adults lacks strong evidence of health benefit and broad coverage for adult ABA is therefore not supported without further high-quality comparative research.
Coding and Procedure Codes
ABA-related CPT Codes referencedCPT
97155
Adaptive behavior treatment with protocol modification, administered by physician or other qualified health care professional, which may include simultaneous direction of technician, face-to-face with one patient; each 15 minutes.
97157
Multiple-family group adaptive behavior treatment guidance, administered by physician or other qualified health care professional (without the patient present), face-to-face with multiple sets of guardians/caregivers, each 15 minutes.
Covered CPT CodesCPTCovered
97151
Behavior identification assessment, administered by a physician or other qualified health care professional, each 15 minutes of the physician's or other qualified health care professional's time face-to-face with patient and/or guardian(s)/caregiver(s) administering assessments and discussing findings and recommendations, and non-face-to-face analyzing past data, scoring/interpreting the assessment, and preparing the report/treatment plan.
97152
Behavior identification-supporting assessment, administered by one technician under the direction of a physician or other qualified health care professional, face-to-face with the patient; each 15 minutes.
97153
Adaptive behavior treatment by protocol, administered by technician under the direction of a physician or other qualified health care professional, face-to-face with one patient, each 15 minutes.
97154
Group adaptive behavior treatment by protocol, administered by technician under the direction of a physician or other qualified health care professional, face-to-face with two or more patients, each 15 minutes.
97155
Adaptive behavior treatment with protocol modification, administered by physician or other qualified health care professional, which may include simultaneous direction of technician, face-to-face with one patient; each 15 minutes.
97156
Family adaptive behavior treatment guidance, administered by physician or other qualified health care professional (with or without the patient present), face-to-face with guardian(s)/caregiver(s), each 15 minutes.
97157
Multiple-family group adaptive behavior treatment guidance, administered by physician or other qualified health care professional (without the patient present), face-to-face with multiple sets of guardians/caregivers, each 15 minutes.
97158
Group adaptive behavior treatment with protocol modification, administered by physician or other qualified health care professional, face-to-face with multiple patients, each 15 minutes.
Tracking / T CodesCPTCovered
0362T
Behavior identification supporting assessment, each 15 minutes of technicians' time face-to-face with a patient, requiring the following components: administration by the physician or other qualified health care professional who is on site; with the assistance of two or more technicians; for a patient who exhibits destructive behavior; completion in an environment that is customized to the patient's behavior.
0373T
Adaptive behavior treatment with protocol modification, each 15 minutes of technicians' time face-to-face with a patient, requiring the following components: administration by the physician or other qualified health care professional who is on site; with the assistance of two or more technicians; for a patient who exhibits destructive behavior; completion in an environment that is customized to the patient's behavior.
Prior authorization is required for outpatient ABA therapy. All requests (initial and continuation) must be submitted using the designated FEP Prior Approval Form and include the ABA treatment assessment. Approval is specific to ABA services and does not guarantee coverage of unrelated therapies.
Use the FEP Prior Approval Form for all outpatient ABA prior approval requests.
Authorizations apply only to ABA therapy and do not include occupational, speech, physical, educational, or other services.
Prior Authorization
Prior Authorization — Medical Necessity & Clinical-Effectiveness
Prior authorization determinations require demonstration of medical necessity based on clinical-effectiveness justification. Requests must show anticipated clinically meaningful, functional improvements tied to individualized treatment goals.
Medical necessity review of progress will occur every 6 months (or sooner if warranted); continuation requests must document ongoing benefit.
If insufficient improvement is demonstrated across successive authorizations, coverage may be reduced or denied.
Key Definitions and Terminology
ABA (Applied Behavior Analysis)
DefinitionApplied Behavior Analysis (ABA) is a therapeutic approach that identifies environmental variables influencing socially significant behavior and uses individualized strategies (direct observation, measurement, functional analysis, and environmental modification) to teach communication, adaptive skills, and social interactions.
Core methodsUses direct observation, measurement, functional analysis, antecedent/consequence manipulation, and structured/naturalistic teaching methods to produce meaningful behavior change.
Treatment modelsIncludes focused ABA (limited number of behavioral targets) and comprehensive ABA (addresses multiple developmental domains), with intensity and duration individualized to needs.
ASD (Autism Spectrum Disorder)
DefinitionAutism Spectrum Disorder (ASD) is a lifelong biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and interaction and by restricted, repetitive patterns of behavior, interests, and activities.
Applicable Levels of Care
Outpatient (duplicate reference for authorization notes)
Outpatient ABA authorization and documentation should include the following clinical criteria:
BCBA-submitted medical record: A complete medical record from the BCBA must be submitted for initial and continued requests and include collected data (graphs, progress notes), assessments (ABLLS, VB-MAPP), individualized treatment plan, measurable six-month goals, mastery criteria, estimated date of mastery, and number of hours/week estimated to achieve each goal.
Required documentation for authorization
Prior authorization requirement: Prior approval is required for outpatient ABA therapy; authorization is specific to ABA and does not include other therapies (e.g., OT, speech, PT, educational services).
Prior authorization note
Outpatient ABA / ongoing therapy
Ongoing outpatient ABA therapy requests should meet the following criteria and operational expectations:
ABA Clinical, Provider & Delivery Criteria
ABA Clinical Criteria
ABA-specific clinical and documentation criteria (ALL required):
Diagnosis and medical evaluation: Member must have DSM-5 consistent diagnosis of ASD and a completed medical evaluation including neurological exam.
Diagnosis requirement
Provider qualifications: BCBA/BCBA-D (or licensed MD/DO/psychologist) must conduct assessments and supervise treatment; BCaBA and RBT must be supervised per BACB requirements.
Credential and supervision rules
Assessment tools: Preferred assessments include ABLLS, VB-MAPP, or other developmentally appropriate measures; adaptive behavior testing (e.g., Vineland, ABAS, BASC-3, PDDBI) annually for continued care.
Assessment tools and frequency
Treatment Modalities and Telehealth
Telehealth for supervision/education
Telehealth is permitted for supervision and caregiver education under specified limits:
Allowed uses: Telehealth/telemedicine may be used for parent education (e.g., 97156, 97157) and direct supervision activities (e.g., 97155) if allowed by the member benefit plan.
Allowed telehealth uses
Combination with face-to-face recommended: Telehealth-delivered supervision or education is recommended to be combined with face-to-face service delivery for direct supervision activities.
Operational recommendation
Not for direct ABA delivery: Telehealth is not an approved method for direct ABA service delivery (e.g., 97157 for direct treatment delivery).
Telehealth limitation
Authorization Intervals, Hours Justification, and Intensity
ABA therapy authorization — Review intervals
Concurrent review intervalMedical necessity review requests may be submitted no more often than every 3 months; routine medical necessity review is performed every 6 months.
RationaleSix-month reviews assess progress toward measurable goals; earlier reviews allowed if clinically required but not more frequently than every 3 months.
ApplicationApplies to prior authorization and continued treatment service requests for ABA therapy.
Provider justification for requested hours
Justification requirementProviders must justify requested hours: hours should reflect the number of behavioral targets, services, and functional skills to be addressed and include a clinical summary justifying hours per target.
Caregiver training ratio
Background and Evidence Context
Background: Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder characterized by persistent deficits in social communication and restricted, repetitive behaviors. Applied Behavior Analysis (ABA) is a behavioral intervention approach that identifies environmental variables influencing socially significant behavior and uses individualized strategies to teach communication, adaptive skills, and social interactions. ABA is commonly used as part of comprehensive treatment models for individuals with ASD and is intended to target functionally significant deficits through data-driven, individualized plans.
ABA therapy authorization
Authorization and review timing for ABA therapy:
Review frequency: Medical necessity review of the individual's progress shall be performed every six months; requests for earlier review may be made but no more than every three months.Every 6 months (may request no more than every 3 months)
Authorization timing
Documentation to support hours requested: Providers must justify requested hours with a clinical summary tying hours to behavioral targets and functional skills to be addressed.
Policy Revision History
2016-12-01policy_created
Policy and evidence review were created (initial evidence review created December 2016).
2017-01-01interim_review
Interim review and policy revisions recorded in January 2017.
2017-03-01interim_review
Interim review and policy revisions recorded in March 2017.
Policy Summary
PayerBlue Cross Blue Shield - Iowa
PolicyApplied Behavior Analysis (ABA) for the Treatment of Autism
Policy CodePolicy N/A
Change TypeNo material changes
Effective DateDec 1, 2016
Next Review Date
Key ActionSubmit prior authorization requests with a complete BCBA-authored medical record including assessments, individualized measurable goals, and collected progress data.
Documentation of treatment participants, procedures, and setting, and demonstration that operational control will be transferred to caregivers as appropriate.
Implementation documentation
Transition and aftercare planning should begin during early phases of treatment (not required for initial request but recommended).
Planning recommendation
Telehealth limitations: Telehealth/telemedicine is not an approved method for direct ABA delivery; telehealth may be used for parent education (e.g., 97156, 97157) and direct supervision activities (e.g., 97155) if covered by the member benefit plan and is recommended to be combined with face-to-face supervision.
Telehealth guidance
Continued services align with either comprehensive goals (reduce chronological-developmental gap) or focused goals (reduce burden of targeted symptoms and increase appropriate behaviors).
Continued treatment scope
Setting and intensity: Treatment provided in the least restrictive and most clinically appropriate environment; intensity appropriate to individual's ability to participate; occurs where target behaviors occur or where treatment will impact behaviors.
Continued setting/intensity
Provider qualifications: Supervisor/provider must be licensed MD/DO/psychologist in-state or BACB-certified (BCBA/BCBA-D) with required supervision for lower-level certificants.
Continued provider credential requirement
Progress documentation: Complete medical record from the BCBA including collected data (graphs, progress notes), assessments (ABLLS, VB-MAPP), individualized treatment plan with measurable goals, mastery criteria, estimated date of mastery, number of hours/week estimated to achieve each goal, FBA as indicated, and documentation of participants/procedures/setting; concurrent review must demonstrate significant improvement and clinically significant progress.
Progress and data requirements for continued coverage
Review interval: Medical necessity review of progress shall be performed every six months; review requests may be made no more than every 3 months if earlier review is required.Every 6 months (may request no more than every 3 months)
Authorization review timing
Generalization capacity
Documentation Required
BCBA Oversight and Written Plan Required
Prior authorization requests must be overseen by a BCBA or BCBA-D. The BCBA is responsible for assessment, development and supervision of behavior analytic interventions, and documentation of onsite supervision.
BCBA/BCBA‑D must submit and sign treatment plans and supervision documentation.
Undergraduate-level behavior analysts must be supervised by BCBA/BCBA‑D; RBTs and technicians must be supervised per BCBA direction.
Documentation Required
Required Documentation for Requests
Required documentation must accompany all initial and continued prior authorization requests. The BCBA must submit a complete medical record including standardized and non-standardized assessments, data, and treatment planning materials.
Preferred assessments: ABLLS, VB‑MAPP, or other developmentally appropriate instruments.
Functional Behavior Assessment with operational definitions and data collection plan.
Individualized treatment plan with measurable goals (expected to be reasonably achievable within six months) including baseline, mastery criteria, estimated date of mastery, and generalization plan.
Documentation of treatment participants, procedures, setting, and onsite supervision notes.
Documentation Required
Required Documentation Elements
Prior approval submissions should include specific supporting documentation elements: graphs and celebration charts, progress notes linking interventions to goals, ABLLS/VB‑MAPP or equivalent assessments, caregiver training curriculum, and a written transition/discharge plan.
Progress data (graphs) demonstrating response to interventions and linkage to targeted goals.
Parent/caregiver training plans with measurable caregiver skill acquisition goals and monitoring.
Written transition and aftercare planning, with roles/responsibilities and timeline for step‑down.
Documentation Required
Outcome Measurement & Evidence Justification
When requesting or continuing ABA services, providers should explicitly justify the selection of interventions and expected outcomes using a study-selection and outcome‑measurement approach. Documentation should specify prespecified, clinically meaningful improvement thresholds.
Describe comparator(s) considered (e.g., standard clinical care, educational, pharmacologic, psychological) when applicable.
Identify outcome measures to be used and the prespecified improvement thresholds that will indicate clinical benefit.
Billing Rule
Prior Authorization and Coding
Coding must be accurate on all prior authorization requests and claims. Use the listed CPT and tracking codes for ABA services and include supporting documentation linking billed codes to the supervised treatment plan and progress data.
Document services using CPT codes 97151–97158 and tracking codes 0362T, 0373T as appropriate.
Include applicable HCPCS, Revenue, Place of Service, and ICD‑10 diagnosis codes. Incorrect coding may trigger denials.
Prior Authorization
Telehealth Limitations
Telehealth is not an approved delivery method for direct ABA services. Limited use of telehealth/telemedicine is permitted for parent education (e.g., 97156, 97157) and for remote supervision activities (e.g., 97155) only if the member's benefit plan allows telehealth services; it is recommended telehealth be combined with face‑to‑face supervision.
Direct ABA (treatment delivery) via telehealth is not approved.
Telehealth may be used for caregiver guidance and some supervision if allowed by the member's plan and documented in the authorization.
Note
Comparator Consideration & Evidence Limitations
Comparators and evidence limitations should be considered in authorization decisions. The current evidence base has limited long‑term and high‑quality controlled studies, which constrains broad coverage conclusions and requires individualized justification.
Comparators include behavioral, developmental, educational, pharmacological, psychological, and complementary/alternative approaches.
Document the rationale for selecting ABA relative to available comparators and cite relevant evidence where possible.
Denial Risk
Risk of Denial for Lack of Progress
Risk of denial increases if expected progress is not documented. If the member does not demonstrate clinically meaningful improvement or progress toward goals across successive authorization periods, benefit coverage may be reduced or terminated.
Continued authorization requires submitted data demonstrating significant functional progress linked to treatment goals.
Lack of documented generalization to caregivers or natural settings, or missing discharge/transition planning, increases likelihood of denial.
Clinical rangeSeverity ranges from mild social impairment to severe disability, including nonverbal individuals and those with intellectual disability or severe sensory reactions.
Diagnosis noteDiagnosis is based on DSM-5 criteria and typically involves developmental screening followed by comprehensive diagnostic evaluation.
Caregiver Training
DefinitionCaregiver Training is the education and development of caregiver-mediated ABA strategies, protocols, or techniques to facilitate social interaction, skill acquisition, behavior management, and generalization of skills across settings.
Participation expectationCaregiver participation is expected for at least 80% of agreed-upon caregiver training sessions unless contraindicated or declined; if <80% attainable, a plan to increase participation should be included.
Recommended ratioRecommended: 1 hour of caregiver training for the first 10 hours of direct therapy, plus 0.5 hours for each additional 10 hours, with higher ratios when ADLs or imminent transition to lower level of care are involved.
Functional Behavior Assessment
DefinitionFunctional Behavior Assessment (FBA) comprises descriptive assessment procedures to identify environmental events that occur just before (antecedents) and just after (consequences) occurrences of target behaviors to inform intervention.
MethodsInformation may be gathered via caregiver interview, checklists/rating scales, observation and recording of target behaviors, and, when indicated, formal functional analysis procedures.
PurposeFBA provides operational definitions and data to measure progress and to guide selection of interventions for targeted problematic behaviors.
Core Deficits of Autism
Core deficitsPersistent deficits in social communication and social interaction across contexts.
Restricted behaviorsRestricted, repetitive patterns of behavior, interests, and activities that interfere with functioning.
Functional impactDeficits and restricted/repetitive behaviors can range in severity and often impede daily living, communication, and social participation.
ASD Severity Levels 1-3
Level 1 (requiring support)Noticeable deficits in social communication without supports; difficulty initiating interactions and atypical responses to social overtures that cause noticeable impairments; restricted/repetitive behaviors cause significant interference in some contexts.
Level 2 (requiring substantial support)Marked deficits in verbal and nonverbal social communication; social impairments apparent even with supports in place; restricted/repetitive behaviors frequent enough to interfere with functioning across contexts.
Level 3 (requiring very substantial support)Severe deficits in verbal and nonverbal social communication causing severe impairments in functioning; very limited initiation of social interaction and minimal response to social overtures; pervasive restricted/repetitive behaviors that markedly interfere with all spheres of functioning.
Focused ABA
DefinitionFocused ABA is treatment delivered directly to the individual for a limited number of behavioral targets (increasing appropriate behavior or reducing problem behavior) and is appropriate when only a few key functional skills or acute problem behaviors require priority treatment.
IndicationsAppropriate for limited, high-priority targets or acute problem behaviors where concentrated, short-term intervention can address specific needs.
DeliveryIntensity and duration are individualized; focuses on a small set of measurable goals with plans for generalization and caregiver involvement.
Comprehensive ABA
DefinitionComprehensive ABA addresses multiple developmental domains (cognitive, communicative, social, emotional, adaptive) and maladaptive behaviors, typically beginning with structured sessions and integrating naturalistic methods over time.
IndicationsIntended for individuals needing broad, multisystem intervention to reduce the developmental gap across domains rather than addressing only a few targets.
DeliveryOften more intensive and longer in duration than focused ABA, with phased integration into community and natural settings as goals are met.
ABA (short label)
Short labelABA
Full termApplied Behavior Analysis
ContextUsed to describe both focused and comprehensive behavior-analytic treatments for ASD.
TAU / Eclectic comparator
DefinitionTAU / Eclectic comparators refer to treatment-as-usual or mixed 'eclectic' approaches (e.g., TEACCH, PECS, speech/language therapy, occupational therapy, or other behavioral/developmental programs) used as comparators in studies of ABA.
Use in evidenceComparators were classified as TAU when usual care details were not provided; 'eclectic' when a mix of specified teaching approaches was reported in the comparator group.
ImplicationComparative evidence of ABA versus TAU/eclectic shows variable effects with methodological limitations across studies.
Early intensive behavioral intervention (EIBI)
DefinitionEarly intensive behavioral intervention (EIBI) is an ABA-based intensive treatment approach for young children with ASD that typically involves higher hours per week of direct therapy and early start in preschool years.
Evidence noteSystematic reviews and an individual participant data meta-analysis (10 nonrandomized studies, 491 participants) and some RCTs/single-subject literature report improvements in adaptive behavior and IQ at ~2 years versus TAU/eclectic, but studies have methodological limitations and limited long-term follow-up.
Clinical guidanceAAP notes that EIBI is supported by a few RCTs and substantial single-subject literature and that more hours per week were associated with better attainment of individualized goals in some studies.
Treatment intensity justification: Hours requested must correspond to developmental and adaptive behavioral needs and reflect the number of behavioral targets and functional skills to be addressed; clinical justification for hours per target must be provided.
Provider must justify requested hours; see caregiver training ratio recommendations
Caregiver training expectations: Caregiver participation is expected for at least 80% of agreed caregiver training sessions; recommended caregiver training ratio is 1 hour per first 10 hours of direct therapy and 0.5 hours per additional 10 hours unless contraindicated or caregiver declines.>=80% caregiver participation
Caregiver training details
Review interval and documentation: Medical necessity review every six months (requests may be made no more than every 3 months); complete BCBA-submitted records with assessments, treatment plan, and progress data required for continuation.Every 6 months (may request no more than every 3 months)
Operational review timing
Outpatient
Additional outpatient-specific requirements and expectations:
Care coordination and discharge planning: Transition and discharge planning should begin early and include a written plan specifying monitoring, follow-up, roles/responsibilities, and behavioral targets; plan development should involve caregivers and multidisciplinary team and typically begin 3–6 months prior to first change in service.
Discharge/transition planning
Least restrictive and community integration: Treatment should be provided in the least restrictive setting appropriate to clinical needs and integrate treatment in natural settings and community as progress allows.
Setting guidance
Individualized measurable goals: Treatment plans must include individualized, measurable goals addressing core ASD deficits with baseline, mastery criteria, estimated mastery date, generalization plan, and estimated hours/week per goal; goals should be achievable within six months.6 months per goal set
Goal measurement specifics
Functional Behavior Assessment (FBA): FBA required as clinically indicated with operational definitions and data collection to measure progress.
FBA requirement
ABA Clinical Improvement Criteria
Measures that indicate continued-treatment appropriateness and improvement (ALL required):
Demonstrated progress: On concurrent review there must be significant improvement—defined as mastery of at least 50% of stated goals—and clinically significant progress toward developing or restoring function.>=50% goals mastered
If <50% mastered, plan should address barriers and remediation
Connection to long-term goals: Continued six-month goals must link to long-term clinically significant goals; incremental mastery modifications must preserve overall long-term intent.
Goals linkage
Generalization and independence: Evidence that skill acquisition generalizes across contexts and that progress will assist independence and functional improvements.
Measure of functional impact
ABA practice and provider requirements
Practice and provider requirements (ALL of the following):
BCBA/BCBA-D oversight: BCBA or BCBA-D is primarily responsible for conducting systematic behavioral assessments, including functional analyses, designing and supervising behavior-analytic interventions, and supervising BCaBA and RBT staff.
Primary supervisory roles
BCaBA and RBT roles: BCaBA must be supervised by BCBA/BCBA-D and may supervise RBTs; RBTs are paraprofessionals who implement interventions under close ongoing supervision.
Delegated roles and supervision
Caregiver training and documentation: Parent/caregiver training should be individualized and include didactic instruction, modeling, in-vivo coaching, supervised practice, measurable objectives, and documentation of caregiver skill acquisition and fidelity.
Caregiver training specifics
Supervision and documentation frequency: Supervision, treatment plans, and progress documentation must be maintained and submitted by the BCBA; prior authorization requires documentation supporting medical necessity criteria and onsite supervision as indicated.
Documentation and supervision expectations
ABA delivery considerations
Delivery considerations that affect appropriateness and expected outcomes:
Individualization of intensity: Intensity, duration, and complexity of ABA should be individualized based on number/complexity of targets and patient response; evidence suggests higher weekly hours in some children are associated with better attainment of individualized goals.
Intensity varies by clinical need
Caregiver participation impact: High caregiver participation (expected >=80% of agreed training sessions) supports generalization and maintenance of gains; lack of caregiver participation requires an alternative generalization plan.>=80% caregiver participation expected
Effect of caregiver participation
Setting and generalization: Treatment should occur in settings where target behaviors occur and include plans to generalize skills across stimuli, contexts, and individuals as part of the treatment plan.
Setting and generalization planning
AAP practice points
Practice points from professional guidance relevant to coverage and clinical implementation:
AAP summary on early intensive ABA: AAP notes that most evidence-based treatment models are based on ABA; early intensive behavioral intervention has RCT and single-subject support for some children and that greater hours/week were associated with achieving individualized goals; services should be individualized using clinical data and include early identification and transition planning.
AAP practice guidance
System-level recommendations: AAP recommends collaboration of systems of care, planning for adolescence and transition to adult systems, provider education, and family support to optimize outcomes and access to care.
Broader implementation guidance
Telehealth for ABA
Policy stance on telehealth for ABA services:
Direct ABA via telehealth not approved: Telehealth/telemedicine is not an approved method for direct ABA services (97157); direct supervision activities (e.g., 97155) may be covered via telehealth if allowed by the member benefit plan.
Telehealth restriction for direct therapy
Recommendation for hybrid approach: When telehealth is used for supervision or parent education it is recommended to combine with face-to-face service delivery to ensure effective supervision and generalization.
Hybrid delivery recommendation
ABA (Focused and Comprehensive)
Two commonly described ABA treatment models and when each is appropriate:
Focused ABA addresses a limited number of behavioral targets and is appropriate when only a few key functional skills or acute problem behaviors require priority treatment.
Comprehensive ABA addresses multiple developmental domains (cognitive, communicative, social, emotional, adaptive) and maladaptive behaviors, typically beginning in structured sessions and integrating naturalistic methods as progress allows.
Recommended caregiver training: 1 hour per first 10 hours of direct therapy plus 0.5 hours for each additional 10 hours, adjusted if ADLs are targeted or near transition to lower level of care.
DocumentationRequests should include estimated hours/week to achieve each goal and clinical rationale linking intensity to developmental and adaptive needs.
Visit limits and intensity
No prespecified limitsThere are no prespecified visit or hour limits; intensity and duration are individualized and must be documented in the treatment plan.
IndividualizationIntensity should match number and complexity of targets, patient's ability to participate, and least restrictive effective environment.
Documentation requirementTreatment plans must document measurable goals, estimated hours/week per goal, mastery criteria, and plans for generalization and caregiver training.
Operational requirement for visit limits
Note on adult evidence: systematic reviews and literature searches found no controlled trials demonstrating clinically important functional improvements in adults with ASD. Existing reports are limited to small case series or single-case designs; therefore, claims of benefit for adult ABA are constrained by the lack of comparative, high-quality evidence and should be interpreted cautiously when determining coverage.
2017-12-01annual_review
Annual review and policy revision conducted in December 2017.
2018-12-01annual_review
Annual review and policy renewal conducted in December 2018.
2019-12-01annual_review
Annual review and policy revision conducted in December 2019.
2020-02-01interim_review
Interim review and policy revision recorded in February 2020.
2020-05-01interim_review
Interim review and policy revision recorded in May 2020.
2020-12-01annual_review
Annual review and policy renewal conducted in December 2020.
2021-03-01interim_review
Interim review and policy revision recorded in March 2021.
2021-12-01annual_review
Annual review and policy revision conducted in December 2021.
2022-12-01annual_review
Annual review and policy renewal conducted in December 2022.
2023-12-01annual_review
Annual review and policy revision conducted in December 2023.
2024-12-01annual_review_and_revisionLatest
Most recent annual review and policy revision; evidence review literature searches updated through November 2024 (policy history entry December 2024).